Avalyn Pharma Inc. Common Stock (AVLN) vs Cronos Group Inc. (CRON)

A side-by-side comparison of Avalyn Pharma Inc. Common Stock and Cronos Group Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Avalyn Pharma Inc. Common Stock logo
AVLN
Avalyn Pharma Inc. Common Stock
$1.17B
$26.29HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
Cronos Group Inc. logo
CRON
Cronos Group Inc.
$1.22B
$3.27HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT

Total return — AVLN vs CRON

growth of $100 · dividends reinvested · last 1y
AVLN -8.3% (-8.3%/yr)CRON +26.0% (+26.0%/yr)CRON compounded faster over this window
90100110120130Start $100$92$126
AVLN CRON

AVLN vs CRON: by the numbers

  • •CRON is the larger company ($1.22B vs $1.17B market cap).
  • •CRON is profitable (30.98% net margin) while AVLN runs a net loss (0.00%).

Metrics side by side

Valuation

MetricAVLNCRON
P/E ratioN/A18.03
P/S ratioN/A5.42
P/B ratio2.931.14
EV / EBITDAN/A27.81
FCF yieldN/A4.08%

Profitability

MetricAVLNCRON
Gross margin0.00%36.16%
Operating margin0.00%-11.96%
Net margin0.00%30.98%
ROEN/A6.53%
ROIC-67.73%1.12%

Growth (annualized)

MetricAVLNCRON
Revenue CAGR (5Y)N/A31.80%
Total return CAGR (5Y)N/A-9.92%

Frequently asked

Is AVLN or CRON more profitable?
CRON runs the higher net margin — AVLN at 0.00% versus CRON at 30.98%.

Go deeper

Full AVLN analysisFull CRON analysisInteractive comparison tool

Dig into the metrics

Cronos P/E ratioAvalyn Pharma Inc. Common Stock ROECronos ROEAvalyn Pharma Inc. Common Stock operating marginCronos operating marginAvalyn Pharma Inc. Common Stock revenue growthCronos revenue growthAvalyn Pharma Inc. Common Stock free cash flowCronos free cash flow

Avalyn Pharma Inc. Common Stock & Cronos appear in these rankings

Fastest Revenue Growth StocksHighest FCF Yield StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.